TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
BNR

Burning Rock Biotech Ltd

Healthcare · Diagnostics & Research

16.00$ -9.3% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement BNR
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +87.9% +82.7% +12.6% +18.1% +10.9% -4.6% -4.0% +4.6%
– +87.0% +46.8% +7.0% +23.9% +27.5% -4.9% -11.9% -10.9%
– +88.4% +102.4% +14.8% +16.0% +4.4% -4.4% -0.2% +11.2%
– +114.8% +49.0% +68.2% +39.4% +14.7% -17.7% -33.1% -28.3%
– +16.1% +49.7% +122.3% +66.9% +15.9% -23.0% -40.2% -51.8%
– +54.0% +49.2% +64.2% +59.9% +17.2% -24.1% -30.3% -36.4%
– – – – – – – – –
– +82.0% -49.9% -92.6% +130.3% +626.5% -100.0% – –
– – – – – – – – –
– -82.2% -144.3% – – +120.8% +20.3% +146.4% -73.6%
– – – – – – – – –
– – – – – – – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?